To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...
RAF-RAS Pathway Inhibition
The Oncogene RAS-RAF pathway hyperactivation drives a large number of cancer types. The aim of this proposal is to inhibit RAF and RAS signalling by targeting critical scaffold...
Lead: Prof. Jens Rauch, Prof. Walter Kolch
